Article
Biochemistry & Molecular Biology
Wen-Shin Chang, Chia-Wen Tsai, Jai-Sing Yang, Yuan-Man Hsu, Liang-Chun Shih, Hong-Yi Chiu, Da-Tian Bau, Fuu-Jen Tsai
Summary: The study revealed that resveratrol can suppress the metastasis and invasion capabilities of cisplatin-resistant oral cancer cells by inhibiting the phosphorylation of ERK and p-38. This signaling cascade may provide insights into the treatment and metastatic mechanisms of drug-resistant oral cancer.
JOURNAL OF FOOD BIOCHEMISTRY
(2021)
Article
Immunology
Sen Zhang, Huangfu Hui, Qinli Zhao, Yujun Li, Lina Wu
Summary: This study revealed that the long noncoding RNA HCP5 is highly expressed in laryngeal squamous cell carcinoma (LSCC) and plays a role in promoting cancer cell growth, migration, and invasion. HCP5 interacts with miR-216a-5p, and its knockdown inhibits the malignant biological function of LSCC cells. Moreover, miR-216a-5p downregulates the expression of ZEB1, a target gene involved in LSCC progression. These findings suggest that targeting HCP5 may be a potential therapeutic strategy for LSCC.
FRONTIERS IN IMMUNOLOGY
(2022)
Article
Cell Biology
Haixu Xu, Jie Zhao, Jinping Li, Zhifeng Zhu, Zhaohai Cui, Ran Liu, Rong Lu, Zhi Yao, Qiong Xu
Summary: This study identifies a novel mechanism in which CAF-derived chemokine CCL5 enhances the metastasis and invasion of HCC through the HIF1 alpha/ZEB1 axis. This finding may have implications for the prognosis of HCC and provides a new therapeutic target for HCC.
CELL DEATH & DISEASE
(2022)
Review
Biochemistry & Molecular Biology
Jung Yoon Jang, Eunok Im, Nam Deuk Kim
Summary: This paper comprehensively summarizes the effects of resveratrol on inducing programmed cell death (PCD) such as apoptosis, autophagy, and necroptosis, as well as the development of synthetic resveratrol derivatives and analogues as novel anticancer drugs.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
(2022)
Article
Biochemistry & Molecular Biology
Anindya Dutta, Nilanjana Maji, Pallabi Sengupta, Nilanjan Banerjee, Swarnali Kar, Gopeswar Mukherjee, Subhrangsu Chatterjee, Moitri Basu
Summary: Our study identified the crucial role of nucleolin in facilitating SP1 transcription factor binding to the ZEB1 promoter, leading to the activation of ZEB1 transcription. Stabilization of G-quadruplex with TMPyP4 represses ZEB1 transcription and inhibits cell invasiveness. These findings suggest that small molecule induced G-quadruplex stabilization may serve as a potential molecular switch to regulate gene expression.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
(2021)
Article
Anatomy & Morphology
Yanfei Li, Xia Yun, Jiaojiao Li, Meilin Bai
Summary: In this study, the researchers found that the expression levels of IGHG1, ZEB1, and CSTF2T were all high in melanoma cells. ZEB1 directly binds to the IGHG1 promoter, promoting melanoma cell proliferation and invasion. CSTF2T directly binds to ZEB1 mRNA, and silencing CSTF2T inhibits ZEB1 expression, thereby suppressing melanoma cell proliferation and invasion.
Article
Endocrinology & Metabolism
Xin Xie, Ning Zhang, Hongchao He, Xiaojing Wang, Wenbin Rui, Danfeng Xu, Wei He, Yu Zhu
Summary: DDR1a promotes invasion and metastasis in bladder cancer by regulating the ZEB1/COL4 axis.
JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS
(2023)
Article
Biochemistry & Molecular Biology
Liang Chen, Bing-Zhang Wang, Jun Xie, Ri-Yan Zhang, Chen Jin, Wei-Kai Chen, Kang-Hao Fang, Chen-Xuan Hong, Tian-Hao Xu, Cheng-Bin Huang, Lei Yang, She-Ji Weng
Summary: The study indicates the important role of SIRT3 in glucocorticoid-induced osteonecrosis of the femoral head. Resveratrol can reduce oxidative stress and mitochondrial damage by activating SIRT3, and promote osteogenic differentiation of BMSCs through the AMPK/PGC-1 alpha/SIRT3 axis. Resveratrol administration can prevent GIONFH, enhance SIRT3 expression, and reduce oxidative levels in affected rats.
FREE RADICAL BIOLOGY AND MEDICINE
(2021)
Article
Oncology
Yannick von Grabowiecki, Vinaya Phatak, Lydia Aschauer, Patricia A. J. Muller
Summary: Rab11-FIP1 is a Rab effector protein involved in endosomal recycling and trafficking, with its expression correlating with tumorigenic and metastatic cell behavior. Mutant p53 has been shown to promote Rab11-FIP1 function, leading to increased invasive behavior and chemoresistance by regulating various proteins.
FRONTIERS IN ONCOLOGY
(2021)
Article
Biochemistry & Molecular Biology
Ting-Ann Lin, Wei-Sheng Lin, Ya-Chun Chou, Kalyanam Nagabhushanam, Chi-Tang Ho, Min-Hisung Pan
Summary: The study demonstrates that OXY inhibits human colon cancer cell migration by regulating both EMT and miRNAs, suggesting its potential anti-metastatic properties in CRC.
Article
Oncology
Chunli Wei, Md. Asaduzzaman Khan, Jiaman Du, Jingliang Cheng, Mousumi Tania, Elaine Lai-Han Leung, Junjiang Fu
Summary: Cancer metastasis is a leading cause of cancer-related death, and this study demonstrates that cordycepin (CD), a compound found in the Cordyceps mushroom, has antimetastatic effects in triple-negative breast cancer (TNBC) by inhibiting the epithelial-to-mesenchymal transition (EMT) process. CD inhibits cell growth, migration, and invasion by inactivating EMT signaling pathways and reducing the expression of specific EMT-inducing transcription factors (EMT-TFs) such as TWIST1 and SLUG. In vivo studies in mice also reveal the inhibitory effect of CD on cancer cell growth and metastasis. Additionally, combination treatment with thymoquinone (TQ), another natural product with promising anticancer properties, shows additive or synergistic anti-metastasis effects.
FRONTIERS IN ONCOLOGY
(2022)
Article
Oncology
Lei Jiang, Yan Chen, Guangtao Min, Jun Wang, Wei Chen, Hongpeng Wang, Xiangwen Wang, Nan Yao
Summary: BAG4 has been found to be overexpressed in gastric cancer tissues compared to normal tissues, and its elevated expression is associated with advanced tumor characteristics and poor patient outcomes. Mechanistically, BAG4 promotes invasion and metastasis of gastric cancer cells by activating the PI3K/AKT/NF-kappa B/ZEB1 axis to induce epithelial-mesenchymal transition.
Article
Oncology
Yen-Yun Wang, Anupama Vadhan, Ping-Ho Chen, Yen-Lung Lee, Chih-Yeh Chao, Kuang-Hung Cheng, Yu-Chiuan Chang, Stephen Chu-Sung Hu, Shyng-Shiou F. Yuan
Summary: The study investigated the role of CD44 in lung cancer metastasis through clinical, in vitro, and in vivo studies, revealing that CD44 promotes migration and invasion abilities of lung cancer cells. Understanding and targeting CD44 may offer potential therapeutic strategies to decrease lung cancer metastasis.
Article
Cell Biology
Zheyuan Xu, Ran Wang, Xu Li, Limin Yang, Hao Peng, Yang Wang, Ping Wang
Summary: The gene RHBDD1 is upregulated in human NSCLC tissues and cell lines, particularly in A549 and H1650 cells. Silencing of RHBDD1 inhibits NSCLC cell proliferation, induces apoptosis, and reduces cell invasion through the ZEB1/PI3K/AKT signaling pathway. Targeting RHBDD1 could potentially serve as a diagnostic and therapeutic strategy for NSCLC treatment.
JOURNAL OF MOLECULAR HISTOLOGY
(2021)
Article
Oncology
Yunhee Lee, Dongjoon Ko, Junghwa Yoon, Younghoon Lee, Semi Kim
Summary: TMEM52B has been identified as a novel gene expressed widely in normal human tissues. Suppression of TMEM52B in colon cancer cells leads to enhanced epithelial-mesenchymal transition (EMT), invasion, and survival, potentially through multiple signaling pathways. Clinical data suggest that high TMEM52B expression is associated with increased patient survival in various types of cancer.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
(2021)
Article
Chemistry, Medicinal
Seung Hwa Kim, Kyung Hwa Cho, Yu Na Kim, Bo Young Jeong, Chang Gyo Park, Gang Min Hur, Hoi Young Lee
ARCHIVES OF PHARMACAL RESEARCH
(2016)
Article
Infectious Diseases
Bo Young Jeong, Se-Ra Park, Sungkwon Cho, Seong-Lan Yu, Hoi Young Lee, Chang Gyo Park, Jaeku Kang, Da-Young Jung, Moon Hyang Park, Won-Min Hwang, Sung-Ro Yun, Ju-Young Jung, Se-Hee Yoon
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
(2018)
Article
Multidisciplinary Sciences
Bo Young Jeong, Hoi Young Lee, Chang Gyo Park, Jaeku Kang, Seong-Lan Yu, Du-ri Choi, Seung-Yun Han, Moon Hyang Park, Sungkwon Cho, Soo Young Lee, Won-Min Hwang, Sung-Ro Yun, Hye-Myung Ryu, Eun-Joo Oh, Sun-Hee Park, Yong-Lim Kim, Se-Hee Yoon
Article
Chemistry, Medicinal
Kyung Hwa Cho, Bo Young Jeong, Chang Gyo Park, Hoi Young Lee
ARCHIVES OF PHARMACAL RESEARCH
(2019)
Article
Multidisciplinary Sciences
Sungkwon Cho, Seong-Lan Yu, Jaeku Kang, Bo Young Jeong, Hoi Young Lee, Chang Gyo Park, Young-Bin Yu, Dong-Chan Jin, Won-Min Hwang, Sung-Ro Yun, Ho Seung Song, Moon Hyang Park, Se-Hee Yoon
Article
Biochemistry & Molecular Biology
Bo Young Jeong, Kyung Hwa Cho, Se-Hee Yoon, Chang Gyo Park, Hwan-Woo Park, Hoi Young Lee
Summary: LPA induces DDR2 expression through the activation of the PI3K/Akt/mTOR/HIF-1α/Twist1 signaling axes, aggravating ovarian cancer cell invasion.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
(2021)
Article
Chemistry, Medicinal
Su Jin Cho, Bo Young Jeong, Young Soo Song, Chang Gyo Park, Do Yeun Cho, Hoi Young Lee
Summary: This study identifies the important role of STAT3 in RCP-induced cancer cell invasion. The expression levels of RCP and p-STAT3 are closely correlated in ovarian cancer patients, and high expression of both proteins is associated with poorer survival rates. Mechanistically, RCP induces STAT3 phosphorylation in cancer cells, and the beta 1 integrin/EGFR axis is important for this process. Furthermore, STAT3 activates NF-kappa B to promote Slug and MT1-MMP expression, contributing to cancer cell invasion.
ARCHIVES OF PHARMACAL RESEARCH
(2022)
Article
Oncology
Bo Young Jeong, Kyung Hwa Cho, Kang Jin Jeong, Su Jin Cho, Minho Won, Seung Hwa Kim, Nam Hoon Cho, Gang Min Hur, Se-Hee Yoon, Hwan-Woo Park, Gordon B. Mills, Hoi Young Lee
Summary: Cancer-associated fibroblasts (CAFs) enhance their invasiveness by secreting more amphiregulin (AREG), which is induced by lysophosphatidic acid (LPA). LPA induces AREG expression in CAFs through the Yes-associated protein (YAP) and Zinc finger E-box binding homeobox 1 (Zeb1) signaling pathways, and this process can be inhibited by metformin, reducing cancer cell invasiveness.